Literature DB >> 9224730

Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase.

G Sun1, S Ke, R J Budde.   

Abstract

Csk is a protein tyrosine kinase that phosphorylates other protein tyrosine kinases of the Src family and down-regulates their activities. It is not known how Csk is regulated. We investigated the possibility that Csk is regulated through phosphorylation by examining if Csk can serve as an in vitro substrate for a panel of protein kinases. We found that Csk was phosphorylated by the cAMP-dependent protein kinase (PKA), but not by protein kinase C, Src, or the fibroblast growth factor receptor kinase. Csk phosphorylation in vitro by PKA is on a serine residue(s) and can reach a stoichiometry of approximately 0.6 mol phosphate per mole of enzyme. Furthermore, incubation with PKA in the presence of ATP and magnesium ion results in a time-dependent decrease in Csk kinase activity. A six-fold decrease in Csk activity (expressed as Vmax/Km ratio) was achieved due to a threefold increase in its Km and a twofold decrease in its Vmax value within 1 h of incubation with the catalytic subunit of PKA and ATP-Mg. Both phosphorylation and inactivation by PKA were blocked by a PKA-specific inhibitor. Csk mutants with a deleted SH2 or SH3 domain retained their ability to be phosphorylated and inactivated by PKA, indicating that the phosphorylation site is located within the catalytic domain. These studies suggest that the cAMP-dependent protein kinase can regulate Csk activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224730     DOI: 10.1006/abbi.1997.0156

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Dopamine Promotes Ascorbate Release from Retinal Neurons: Role of D1 Receptors and the Exchange Protein Directly Activated by cAMP type 2 (EPAC2).

Authors:  Thaísa Godinho da Encarnação; Camila Cabral Portugal; Caio Eduardo Nogueira; Felipe Nascimento Santiago; Renato Socodato; Roberto Paes-de-Carvalho
Journal:  Mol Neurobiol       Date:  2018-02-23       Impact factor: 5.590

2.  TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22.

Authors:  Alicia M Wallis; Ellie C Wallace; Bruce S Hostager; Zuoan Yi; Jon C D Houtman; Gail A Bishop
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

Review 3.  Role and mechanism of action of leucine-rich repeat kinase 1 in bone.

Authors:  Weirong R Xing; Helen Goodluck; Canjun Zeng; Subburaman Mohan
Journal:  Bone Res       Date:  2017-03-14       Impact factor: 13.567

4.  Regulation of the firing activity by PKA-PKC-Src family kinases in cultured neurons of hypothalamic arcuate nucleus.

Authors:  Xiao-Dong Sun; Anqi Wang; Peng Ma; Shan Gong; Jin Tao; Xian-Min Yu; Xinghong Jiang
Journal:  J Neurosci Res       Date:  2019-08-12       Impact factor: 4.164

5.  Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis.

Authors:  Weirong Xing; Jeff Liu; Shaohong Cheng; Peter Vogel; Subburaman Mohan; Robert Brommage
Journal:  J Bone Miner Res       Date:  2013-09       Impact factor: 6.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.